Dana Yaacov-Garbeli - 01 Jan 2022 Form 3 Insider Report for Entera Bio Ltd. (ENTX)

Role
Israel CFO
Signature
/s/ Dana Yaacov-Garbeli
Issuer symbol
ENTX
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
3
Filing time
08 Feb 2022, 15:01:54 UTC
Next filing
09 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENTX Stock Option (right to buy) 01 Jan 2022 Ordinary Shares, par value NIS 0.0000769 per share 35,000 $2.14 Direct F1
holding ENTX Stock Option (right to buy) 01 Jan 2022 Ordinary Shares, par value NIS 0.0000769 per share 120,000 $3.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest over a four-year period that commenced on March 16, 2020, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.
F2 The options vest over a four-year period that commenced on April 21, 2021, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.